SeaStar Medical Holding Corporation (ICU)Healthcare | Biotechnology | Denver, United States | NasdaqCM
3.09 USD
-0.01
(-0.323%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.10 +0.01 (0.324%) ⇧ (Aug. 28, 2026, 4:55 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5 a.m. EDT
The investment case here is fundamentally broken. The company has endured a catastrophic multi-year decline, losing nearly 99.7% of its value over the last four years, with the last three consecutive years showing negative returns. This is not a temporary setback; it is a structural implosion where the market has correctly priced out the business. Despite a recent rally in share price, the underlying reality remains dire: the company is burning through cash with operating losses exceeding 6% of revenue and negative returns on both assets and equity. The balance sheet is fragile, with debt significantly outweighing book value, and there is no dividend to provide any cushion. While the analyst consensus suggests a 'buy' based on a target price far above current levels, this is a speculative gamble on a turnaround that requires massive capital injection and proven product efficacy, neither of which is currently supported by the financial data. For a rational investor, the risk of permanent capital loss far outweighs any potential upside. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.182965 |
| AutoETS | 0.191235 |
| AutoARIMA | 0.191238 |
| AutoTheta | 0.303673 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 0.07 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.059 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 3.119 |
| Revenue per Share | 0.479 |
| Market Cap | 13,617,138 |
| Forward P/E | -1.20 |
| Beta | -1.04 |
| Previous Name | LMF Acquisition Opportunities, Inc. |
| Website | https://seastarmedical.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.66157204 |
| Address1 | 3,513 Brighton Boulevard |
| Address2 | Suite 410 |
| All Time High | 5,500.0 |
| All Time Low | 2.07 |
| Ask | 3.94 |
| Ask Size | 2 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 53,720 |
| Average Daily Volume3 Month | 89,254 |
| Average Volume | 89,254 |
| Average Volume10Days | 53,720 |
| Beta | -1.037 |
| Bid | 2.24 |
| Bid Size | 2 |
| Book Value | 1.008 |
| City | Denver |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.09 |
| Current Ratio | 1.89 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.16 |
| Day Low | 3.06 |
| Debt To Equity | 3.119 |
| Display Name | SeaStar Medical Holding |
| Earnings Call Timestamp End | 1,747,254,600 |
| Earnings Call Timestamp Start | 1,747,254,600 |
| Earnings Timestamp End | 1,755,259,200 |
| Earnings Timestamp Start | 1,754,909,940 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 3.965 |
| Enterprise Value | 6,792,138 |
| Eps Forward | -2.57 |
| Eps Trailing Twelve Months | -1.89 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.6779 |
| Fifty Day Average Change | -0.58790016 |
| Fifty Day Average Change Percent | -0.1598467 |
| Fifty Two Week Change Percent | -66.1572 |
| Fifty Two Week High | 12.5 |
| Fifty Two Week High Change | -9.41 |
| Fifty Two Week High Change Percent | -0.7528 |
| Fifty Two Week Low | 2.07 |
| Fifty Two Week Low Change | 1.02 |
| Fifty Two Week Low Change Percent | 0.49275362 |
| Fifty Two Week Range | 2.07 - 12.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,616,074,200,000 |
| Float Shares | 4,360,878 |
| Forward Eps | -2.57 |
| Forward P E | -1.2023346 |
| Free Cashflow | -9,141,000 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 18 |
| Fullday Change | -0.00999999 |
| Fullday Change Percent | -0.32258 |
| Fullday Price | 3.1 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.92644 |
| Gross Profits | 1,587,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.11623 |
| Held Percent Institutions | 0.07621 |
| Implied Shares Outstanding | 4,406,841 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,767,571,200 |
| Last Split Factor | 1:10 |
| Long Business Summary | SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado. |
| Long Name | SeaStar Medical Holding Corporation |
| Market | us_market |
| Market Cap | 13,617,138 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_111447 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-28 |
| Net Income To Common | -13,627,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 13,573,070 |
| Number Of Analyst Opinions | 2 |
| Open | 3.06 |
| Operating Cashflow | -13,693,000 |
| Operating Margins | -6.16423 |
| Payout Ratio | 0.0 |
| Phone | 844 427 8100 |
| Post Market Change | 0.00999999 |
| Post Market Change Percent | 0.32362428 |
| Post Market Price | 3.1 |
| Post Market Time | 1,787,950,549 |
| Prev Name | LMF Acquisition Opportunities, Inc. |
| Previous Close | 3.1 |
| Price Hint | 4 |
| Price To Book | 3.065476 |
| Price To Sales Trailing12 Months | 7.9492927 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.646 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | -0.00999999 |
| Regular Market Change Percent | -0.32258 |
| Regular Market Day High | 3.16 |
| Regular Market Day Low | 3.06 |
| Regular Market Day Range | 3.06 - 3.16 |
| Regular Market Open | 3.06 |
| Regular Market Previous Close | 3.1 |
| Regular Market Price | 3.09 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 17,091 |
| Return On Assets | -1.02667 |
| Return On Equity | -3.56868 |
| Revenue Growth | 0.82 |
| Revenue Per Share | 0.479 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,406,841 |
| Shares Percent Shares Out | 0.0276 |
| Shares Short | 121,687 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 138,925 |
| Short Name | SeaStar Medical Holding Corpora |
| Short Percent Of Float | 0.0278 |
| Short Ratio | 1.65 |
| Source Interval | 15 |
| State | CO |
| Symbol | ICU |
| Target High Price | 12.0 |
| Target Low Price | 8.0 |
| Target Mean Price | 10.0 |
| Target Median Price | 10.0 |
| Total Cash | 6,959,000 |
| Total Cash Per Share | 1.579 |
| Total Debt | 134,000 |
| Total Revenue | 1,713,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.89 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.30595 |
| Two Hundred Day Average Change | -0.21595001 |
| Two Hundred Day Average Change Percent | -0.065321624 |
| Type Disp | Equity |
| Volume | 17,091 |
| Website | https://seastarmedical.com |
| Zip | 80,216 |